Novonix Stock Cash And Equivalents

NVNXF Stock  USD 0.36  0.01  2.86%   
Novonix fundamentals help investors to digest information that contributes to Novonix's financial success or failures. It also enables traders to predict the movement of Novonix Pink Sheet. The fundamental analysis module provides a way to measure Novonix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Novonix pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Novonix Company Cash And Equivalents Analysis

Novonix's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cash

 = 

Bank Deposits

+

Liquidities

More About Cash And Equivalents | All Equity Analysis

Current Novonix Cash And Equivalents

    
  207.08 M  
Most of Novonix's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Novonix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Competition

In accordance with the recently published financial statements, Novonix has 207.08 M in Cash And Equivalents. This is 47.31% lower than that of the Industrials sector and significantly higher than that of the Electrical Equipment & Parts industry. The cash and equivalents for all United States stocks is 92.34% higher than that of the company.

Novonix Cash And Equivalents Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Novonix's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Novonix could also be used in its relative valuation, which is a method of valuing Novonix by comparing valuation metrics of similar companies.
Novonix is currently under evaluation in cash and equivalents category among its peers.

Novonix Fundamentals

About Novonix Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Novonix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novonix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novonix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Novonix Pink Sheet

Novonix financial ratios help investors to determine whether Novonix Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Novonix with respect to the benefits of owning Novonix security.